African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance.

Autor: Deka R; VA San Diego Health Care System, La Jolla, CA, USA. rdeka@ucsd.edu.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, CA, USA. rdeka@ucsd.edu., Parsons JK; Department of Urology, University of California San Diego School of Medicine, La Jolla, CA, USA., Simpson DR; VA San Diego Health Care System, La Jolla, CA, USA.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, CA, USA., Riviere P; VA San Diego Health Care System, La Jolla, CA, USA.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, CA, USA., Nalawade V; VA San Diego Health Care System, La Jolla, CA, USA.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, CA, USA., Vitzthum LK; VA San Diego Health Care System, La Jolla, CA, USA.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, CA, USA., Kader AK; Department of Urology, University of California San Diego School of Medicine, La Jolla, CA, USA., Kane CJ; Department of Urology, University of California San Diego School of Medicine, La Jolla, CA, USA., Rock CS; VA San Diego Health Care System, La Jolla, CA, USA.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, CA, USA., Murphy JD; VA San Diego Health Care System, La Jolla, CA, USA.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, CA, USA., Rose BS; VA San Diego Health Care System, La Jolla, CA, USA.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, CA, USA.; Department of Urology, University of California San Diego School of Medicine, La Jolla, CA, USA.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2020 Dec; Vol. 23 (4), pp. 581-588. Date of Electronic Publication: 2020 Apr 23.

Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.

Autor: Rogy MA; Department of Surgery, New York Hospital, Cornell University Medical College, New York 10021., Coyle SM, Oldenburg HS, Rock CS, Barie PS, Van Zee KJ, Smith CG, Moldawer LL, Lowry SF

Publikováno v: Journal of the American College of Surgeons [J Am Coll Surg] 1994 Feb; Vol. 178 (2), pp. 132-8.

Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humans.

Autor: Rock CS; Department of Surgery, New York Hospital-Cornell University Medical College, NY 10021., Coyle SM, Keogh CV, Lazarus DD, Hawes AS, Leskiw M, Moldawer LL, Stein TP, Lowry SF

Publikováno v: Surgery [Surgery] 1992 Aug; Vol. 112 (2), pp. 467-74.

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo.

Autor: Van Zee KJ; Laboratory of Surgical Metabolism, New York Hospital-Cornell University Medical Center, NY 10021., Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 1992 Jun 01; Vol. 89 (11), pp. 4845-9.

Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.

Autor: Fischer E; Department of Surgery, Cornell University Medical College, New York, NY 10021., Van Zee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, Dinarello CA, Lowry SF, Moldawer LL

Publikováno v: Blood [Blood] 1992 May 01; Vol. 79 (9), pp. 2196-200.